Aventria elevates care outcomes and your brand growth with tech-driven and agency solutions that support HCPs, patients, payers, and brands.

Are you challenged by intensifying payer impact on the cost of brand access and its negative effect on gross-to-net revenue?

Learn how EHRs support timely diagnosis, streamline resources, and facilitate holistic care planning for improved treatment outcomes.

EHRs grow markets and brands, educate providers, and improve the patient journey. See how EHRs change customer behavior.

Need process to galvanize best thinking of your organization for a robust strategy during deep uncertainty?

Looking to improve the patient experience part of the Quintuple Aim? Read an industry expert’s story as a patient for journey.

Not meeting the goals of the Quintuple Aim means decision-makers will not see the value in your product. Learn how Aventria can help.

Learn how life sciences and pharma companies can close the care and performance measure gaps in patients with CKD and diabetes.

Discover how integrating robust market access planning is crucial for a successful brand launch and commercialization.

Pharmaceutical vice presidents, executive directors, brand leads, marketing leads, and commercial leads: The healthcare marketplace is...

Pharmaceutical vice presidents, executive directors, brand leads, marketing leads, and commercial leads: In the vast and complex world...

Pharmaceutical vice presidents, executive directors, brand leads, marketing leads, and commercial leads: Are customer collaborations...

Discover how to overcome access issues to prescribers and complement field efforts with nonpersonal promotions. Read more.

Payer access controls can result in patients abandoning Rxs. RxRecovery™ counters payer access challenges that contributes to brand revenue.

Pharmaceutical SVP/VP Market Access, VP Key Accounts, SVP Therapeutic Business Units, Brand Directors, Directors of Patient Support...

EHR integration changed how messages and resources for patients and providers are delivered to where they are. Aventria helped lead the way.

Peter Neumann, CEVR director, discussed CMS drug negotiation provisions in the IRA and implications on a Relentless Health Value™ podcast.

The IRA creates a game-changing set of considerations and imperatives for Pharma and the healthcare system. An Aventria Executive ThinkTank™

An overabundance of major healthcare trends (cost of access, changing stakeholder roles, competition for patient control, legislative...

Many brands are challenged to transform their approach for reaching targeted patients with data-driven, segment-specific messages...